M. Oztas Et Al. , "DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?," Annual European Congress of Rheumatology (EULAR) , vol.79, ELECTR NETWORK, pp.843, 2020
Oztas, M. Et Al. 2020. DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?. Annual European Congress of Rheumatology (EULAR) , (ELECTR NETWORK), 843.
Oztas, M., Ugurlu, S., Selvi, O., Ergezen, B., & Ozdogan, H., (2020). DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS? . Annual European Congress of Rheumatology (EULAR) (pp.843). , ELECTR NETWORK
Oztas, M. Et Al. "DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?," Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2020
Oztas, M. Et Al. "DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?." Annual European Congress of Rheumatology (EULAR) , ELECTR NETWORK, pp.843, 2020
Oztas, M. Et Al. (2020) . "DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?." Annual European Congress of Rheumatology (EULAR) , ELECTR NETWORK, p.843.
@conferencepaper{conferencepaper, author={M. Oztas Et Al. }, title={DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?}, congress name={Annual European Congress of Rheumatology (EULAR)}, city={}, country={ELECTR NETWORK}, year={2020}, pages={843} }